Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
VN2R17P (vomeronasal 2 receptor 17, pseudogene) is annotated in the human genome at chromosome 19q13.43 and is part of the vomeronasal receptor family. Vomeronasal receptors are G protein-coupled receptors (GPCRs) that mediate pheromone detection in vertebrates, but the VN2R17P locus in humans is classified as a pseudogene and does not encode a functional receptor[1][3][5]. This means it does not produce a protein product and has no known role in human physiology or disease. It is often cataloged alongside other vomeronasal-related pseudogenes reflecting evolutionary remnants rather than current biological activity[1][3][5].
None. No drugs target the gene or act via this mechanism
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vomeronasal 2 receptor 17, pseudogene (VN2R17P).